BIOMAT Database Logo BIOMAT Database Logo

Multiple-dose cimetidine administration does not influence the single-dose pharmacokinetics of quinapril and its active metabolite (CI-928). 1988

J J Ferry, and A B Cetnarowski, and A J Sedman, and R W Thomas, and A M Horvath
Warner-Lambert/Parke-Davis, Pharmacokinetics-Drug Metabolism Department, Ann Arbor, Michigan.

The potential effect of cimetidine on the pharmacokinetic profiles of quinapril and its active metabolite CI-928 was evaluated in eight healthy volunteers. Each subject received a single 40-mg quinapril dose on days 1 and 12 and cimetidine 300 mg four times daily on days 8 through 13. Serial blood and urine samples were collected for assay of quinapril and CI-928 concentrations. No statistically significant differences were observed in quinapril or CI-928 Cmax, tmax, AUC(0-infinity), beta, or percent of dose excreted in urine values for quinapril administered alone and in combination with cimetidine. Therefore, multiple-dose cimetidine administration does not influence the single-dose pharmacokinetics of quinapril and its active metabolite, CI-928, in healthy volunteers.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008297 Male Males
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077583 Quinapril A tetrahydroisoquinoline derivative and ANGIOTENSIN CONVERTING ENZYME inhibitor that is used in the treatment of HYPERTENSION and HEART FAILURE. 2-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid,Accupril,CI 906,CI-906,PD 109452-2,PD-109,452-2,Quinapril Hydrochloride,PD 109,452 2,PD 109452 2,PD 1094522
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D044005 Tetrahydroisoquinolines A group of ISOQUINOLINES in which the nitrogen containing ring is protonated. They derive from the non-enzymatic Pictet-Spengler condensation of CATECHOLAMINES with ALDEHYDES. Tetrahydro-Isoquinoline,1,2,3,4-Tetrahydroisoquinolines,Tetrahydro-Isoquinolines,Tetrahydro Isoquinoline,Tetrahydro Isoquinolines

Related Publications

J J Ferry, and A B Cetnarowski, and A J Sedman, and R W Thomas, and A M Horvath
Multiple-dose propranolol administration does not influence the single dose pharmacokinetics of quinapril and its active metabolite (quinaprilat).
April 1990, Biopharmaceutics & drug disposition,
J J Ferry, and A B Cetnarowski, and A J Sedman, and R W Thomas, and A M Horvath
Influence of food on the pharmacokinetics of quinapril and its active diacid metabolite, CI-928.
January 1987, Journal of clinical pharmacology,
J J Ferry, and A B Cetnarowski, and A J Sedman, and R W Thomas, and A M Horvath
Single and multiple-dose pharmacokinetics of tepoxalin and its active metabolite after oral administration to rabbits (Oryctolagus cuniculus).
April 2008, Journal of veterinary pharmacology and therapeutics,
J J Ferry, and A B Cetnarowski, and A J Sedman, and R W Thomas, and A M Horvath
Pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in cows following single dose intravenous administration.
August 2003, Journal of veterinary pharmacology and therapeutics,
J J Ferry, and A B Cetnarowski, and A J Sedman, and R W Thomas, and A M Horvath
Cimetidine does not influence the metabolism of the H1-receptor antagonist ebastine to its active metabolite carebastine.
June 1993, British journal of clinical pharmacology,
J J Ferry, and A B Cetnarowski, and A J Sedman, and R W Thomas, and A M Horvath
Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis.
October 1990, Journal of clinical pharmacology,
J J Ferry, and A B Cetnarowski, and A J Sedman, and R W Thomas, and A M Horvath
Pharmacokinetics of quinapril and its active metabolite quinaprilat during continuous ambulatory peritoneal dialysis.
December 1990, Journal of clinical pharmacology,
J J Ferry, and A B Cetnarowski, and A J Sedman, and R W Thomas, and A M Horvath
The influence of cimetidine on single-dose carbamazepine pharmacokinetics.
January 1985, Epilepsia,
J J Ferry, and A B Cetnarowski, and A J Sedman, and R W Thomas, and A M Horvath
Odanacatib does not influence the single dose pharmacokinetics and pharmacodynamics of warfarin.
January 2013, Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique,
J J Ferry, and A B Cetnarowski, and A J Sedman, and R W Thomas, and A M Horvath
Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues.
June 2017, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!